Skip to main content

Table 4 Published Studies on Stereotactic Radiosurgery for Hemangiopericytoma

From: CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas

Series

Institution

Study period

Treatment Modality

No. of Patients/Lesions

Mean Marginal dose (Gy)

Mean Follow up (months)

Tumor control at last FU (%)

Coffey 1993[15]

Mayo Clinic

1990-1992

Gamma Knife

5/11

15.5

14.8

81.8

Galanis 1998[18]

Mayo Clinic

1976-1996

Gamma Knife

10/20

12-18

6-36

100*

Payne 2000[10]

U of Virginia

1991-1999

Gamma Knife

10/12

14

24.8

75

Sheehan 2002[3]

U of Pittsburgh

1987-2001

Gamma Knife

14/15

15

31.3

80

Chang 2003[6]

Stanford

1992-2002

LINAC, CyberKnife

8/8

20.5

44

75

Ecker 2003[8]

Mayo Clinic

1980-2000

Gamma Knife

15/45

16

45.6

93^

Kano 2008[20]

U of Pittsburgh

1989-2006

Gamma Knife

20/29

15

37.9

72.4

Sun 2009[11]

Beijing Neu. Ins.

1994-2006

Gamma Knife

22/58

13.5

26

89.7

Iwai 2009[19]

Osaka City Hosp

1994-2003

Gamma Knife

8/13

15.1

61

100

Olson 2010[9]

U of Virginia

1989-2008

Gamma Knife

21/28

17

69

46.4

Veeravagu 2010

Stanford

2002-2009

CyberKnife

14/22

21.2

37

81.8

  1. *Tumors responded to GKS with decrease or stability in volume, but effect lasted less than 1 year in majority of patients. Study also includes the five patients from Coffey et al. 1993 manuscript.
  2. ^Also includes five patients from Coffey et al. 1993 manuscript.